Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia. Issue 2 (28th January 2022)

Record Type:: Journal Article
Title:: Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia. Issue 2 (28th January 2022)
Main Title:: Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia
Authors:: Kong, Danqing
Li, Yun
Fu, Chengcheng
Hou, Mengjia
Yan, Lingzhi
Shang, Jingjing
Wang, Zhaoyue
Yin, Jie
Yu, Ziqiang
Wu, Depei
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 63:Issue 2(2022)
Journal:: Leukemia & lymphoma
Issue:: Volume 63:Issue 2(2022)
Issue Display:: Volume 63, Issue 2 (2022)
Year:: 2022
Volume:: 63
Issue:: 2
Issue Sort Value:: 2022-0063-0002-0000
Page Start:: 491
Page End:: 494
Publication Date:: 2022-01-28
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2021.1992766 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 20742.xml